Hypersensitivity Reaction
- FDA-Led Research Team Discovers an Autoimmune Mechanism for Serious Drug-Induced Adverse Reactions (May 22, 2012)
From U.S. Food and Drug Administration
On TheBodyPRO.com
- HIV/AIDS Update -- New Intelence Labeling: Severe Skin and Hypersensitivity Reactions (August 2009)
Important drug warning.
To read PDF, click here.
From Tibotec Therapeutics
- Black or White, Ziagen Hypersensitivity Test Works Equally Well, Study Finds (April 1, 2008)
From aidsmap.com
- Can HLA-B*5701 Testing Help Avoid Abacavir Hypersensitivity Reaction? (July 25, 2007)
Avoiding abacavir hypersensitivity reaction may be as easy as screening for the HLA-B*5701 allele in any HIV-infected, abacavir-naive patient for whom abacavir therapy is being considered. Graeme Moyle, M.D., reports.
In 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from TheBodyPRO.com
- Abacavir Hypersensitivity Test Could Be Combined With Drug Resistance Test: Study (June 4, 2007)
From aidsmap.com
- Momentum for HLA-B*5701 Testing to Prevent Abacavir Hypersensitivity Grows (November 16, 2006)
In 8th International Congress on Drug Therapy in HIV Infection
- Abacavir Hypersensitivity Becoming Easier to Predict Using Pharmacogenetic Markers (August 16, 2006)
In XVI International AIDS Conference
- Abacavir Hypersensitivity: Could the Trigger Be in Your Genes? (May 2, 2006)
From aidsmap.com
- Low Incidence of Abacavir Hypersensitivity Reaction in Treatment-Naive and -Experienced Patients (July 26, 2005)
In The 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment
On TheBodyPRO.com
- Severity and Rate of Abacavir Hypersensitivity Reactions Higher Than Previously Believed (February 23, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
VIEW ALL ARTICLES
|
Advertisement
|
Email
Glossary
